Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    15172900 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism
Conditions: Venous Thromboembolism;   Malignancy
Intervention: Other: screening
2 Completed Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Fondaparinux

Indicates status has not been verified in more than two years